About Us

The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH) is a multi-institutional Center of Excellence, funded by the National Institute on Drug Abuse. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and HIV care of people who use substances. To increase the impact of this research, we support researchers in addressing the needs of integrated healthcare system providers and payers. The Center is a collaboration among Weill Cornell Medicine, Boston Medical Center, the University of Pennsylvania, and the University of Miami Miller School of Medicine.

Methodology Core

Bruce Schackman, PhD, MBA
Weill Cornell Medicine
Director

Kathryn McCollister, PhD
University of Miami Miller School of Medicine
Co-Director

Email the Methodology Core

HCV and HIV Core

Benjamin Linas, MD, MPH
Boston Medical Center
Director

Jeffrey Samet, MD, MPH
Boston Medical Center
Co-Director

Email the HCV and HIV Core

Dissemination and Policy Core

Zachary Meisel, MD, MPH, MSHP
Leonard Davis Institute of Health Economics
University of Pennsylvania
Director

Daniel Polsky, PhD
Leonard Davis Institute of Health Economics
University of Pennsylvania
Co-Director

Email the Dissemination and Policy Core

Pilot Grant and Training Core

Brandon Aden, MD, MPH
Weill Cornell Medicine
Director

Email the Pilot Grant and Training Core

Administrative Core

Bruce Schackman, PhD, MBA
Weill Cornell Medicine
Director

Email the Administrative Core